Scientists discover how to quantitatively observe cellular processes taking place on "lab on chip" devices

NewsGuard 100/100 Score

A team of scientists from The University of Texas at Arlington and MIT has figured out how to quantitatively observe cellular processes taking place on so-called "lab on a chip" devices in a silicon environment.

The new technology will be useful in drug development as well as disease diagnosis, researchers say.

In a paper published in Nature's online journal Scientific Reports, the team said it overcame past limitations on quantitative microscopy through an opaque media by working with a new combination of near infrared light and a technique called quantitative phase imaging. Quantitative phase imaging is about a decade old. It uses shifts in phases of light, not staining techniques, to aid specimen imaging - earning the term "label-free."

"To the best of our knowledge, this is the first demonstration of quantitative phase imaging of cellular structure and function in silicon environment," said Assistant Professor of Physics Samarendra Mohanty, head of the Biophysics and Physiology Laboratory at UT Arlington and corresponding author on the paper.

The UT Arlington/MIT team was able to prove success in analyzing specimens through a silicon wafer in two instances. In one, they accomplished full-field imaging of the features of red blood cells to nanometer thickness accuracy. In another, they observed dynamic variation of human embryonic kidney cells in response to change in salt concentration. Mohanty believes that his group's current work on near infrared quantitative phase imaging can lead to non-invasive, label-free monitoring of neuronal activities.

Additional co-authors include: Bipin Joshi and Nelson Cardenas, of UT Arlington; and Ishan Barman, Narahara Chari Dingari, Jaqueline S. Soares and Ramachandra R. Dasari, all of MIT.

"Silicon-based micro devices known as labs-on-a-chip are revolutionizing high throughput analysis of cells and molecules for disease diagnosis and screening of drug effects. However, very little progress has been made in the optical characterization of samples in these systems," said Joshi, a recent graduate and lead author on the paper. "The technology we've developed is well-suited to meet this need."

Barman, now an assistant professor at Johns Hopkins University, said the new paper is a prime example of the type of research he hopes to do - projects pulled by needs of the biomedical community and continually pushing the edge of biophotonic solutions.

"We envision that this significantly expands the visualization possible in silicon based microelectronic and micromechanical devices," he said.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Microfluidic chips advance neurodegenerative disease research